Medicare Enrolled
Dr. Raji Shameem, M.D.
Hematology · Orlando, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shameem from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shameem?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shameem
Dr. Raji Shameem is a hematology specialist in Orlando, FL, with 15 years of NPI registration. Based on federal Medicare data, Dr. Shameem performed 39,078 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Shameem received a total of $668,012 from 93 pharmaceutical and/or device companies across 1204 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shameem is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years of NPI registration
▲ 39,078 Medicare services
$668,012 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗39,078
Medicare services
Bottom 32% in FL for hematology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
10,200 | $0 | $4 |
| Filgrastim injection (Zarxio) for white blood cells An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram. |
8,580 | $0 | $2 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
8,400 | $0 | $5 |
| Denosumab injection (Prolia/Xgeva) | 4,500 | $18 | $46 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
1,220 | $6 | $21 |
| Rituximab-pvvr biosimilar injection, 10 mg An injection of rituximab-pvvr, a biosimilar medication, administered in a 10 mg dose. |
1,150 | $24 | $163 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
900 | $0 | $3 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
512 | $8 | $29 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
471 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 470 | $1 | $30 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
356 | $64 | $207 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
355 | $9 | $66 |
| Anti-nausea injection (ondansetron/Zofran) | 344 | $0 | $15 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
192 | $11 | $76 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
162 | $1 | $6 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
144 | $94 | $407 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
138 | $7 | $68 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
121 | $46 | $206 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
117 | $88 | $329 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
86 | $53 | $185 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
83 | $20 | $100 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
72 | $21 | $142 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
70 | $1 | $3 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
57 | $100 | $450 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
51 | $48 | $176 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
50 | $15 | $86 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
43 | $26 | $155 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
40 | $1 | $9 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
36 | $23 | $93 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
30 | $17 | $59 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
30 | $99 | $384 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
27 | $24 | $170 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
27 | $94 | $346 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
19 | $59 | $199 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
13 | $131 | $549 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
12 | $19 | $67 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
27.4% high complexity
68.4% medium
4.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$668,012
Total received (2018-2024)
Avg $95,430/year across 7 years
Top 1% in FL for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
93
Companies
1,204
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$497,268
2023
$144,869
2022
$12,584
2021
$3,088
2020
$7,286
2019
$2,287
2018
$629
Payments by company (2024)
SOBI, INC
$128,852
Takeda Pharmaceuticals U.S.A., Inc.
$116,348
Ipsen Biopharmaceuticals, Inc
$61,103
E.R. Squibb & Sons, L.L.C.
$47,101
GlaxoSmithKline, LLC.
$41,548
BeiGene USA, Inc.
$29,260
Eisai Inc.
$15,458
JAZZ PHARMACEUTICALS INC.
$15,110
Exelixis Inc.
$12,219
PFIZER INC.
$10,583
Novocure Inc.
$4,697
Pharmacosmos Therapeutics Inc.
$3,616
Rigel Pharmaceuticals, Inc.
$3,394
TAIHO ONCOLOGY, INC.
$2,131
AstraZeneca Pharmaceuticals LP
$1,622
Incyte Corporation
$1,505
Astellas Pharma US Inc
$959
Janssen Scientific Affairs, LLC
$837
GENZYME CORPORATION
$156
Daiichi Sankyo Inc.
$88
Novartis Pharmaceuticals Corporation
$85
Janssen Biotech, Inc.
$64
SUN PHARMACEUTICAL INDUSTRIES INC.
$60
ARRAY BIOPHARMA INC
$59
Dendreon Pharmaceuticals LLC
$51
Gilead Sciences, Inc.
$47
Bayer Healthcare Pharmaceuticals Inc.
$46
RECORDATI_RARE_DISEASES_INC.
$41
Merck Sharp & Dohme LLC
$38
EMD Serono, Inc.
$38
Sumitomo Pharma America, Inc.
$37
Blueprint Medicines Corporation
$29
ADC Therapeutics America, Inc.
$25
Lilly USA, LLC
$24
Genentech USA, Inc.
$23
Celgene Corporation
$15
Top 3 companies account for 61.6% of 2024 payments
All-time payments by company (2018-2024) ›
SOBI, INC
$191,963
Takeda Pharmaceuticals U.S.A., Inc.
$116,419
Ipsen Biopharmaceuticals, Inc
$104,794
E.R. Squibb & Sons, L.L.C.
$80,175
GlaxoSmithKline, LLC.
$41,714
BeiGene USA, Inc.
$29,500
Eisai Inc.
$15,730
JAZZ PHARMACEUTICALS INC.
$15,197
Exelixis Inc.
$12,256
PFIZER INC.
$11,129
Novocure Inc.
$6,075
Incyte Corporation
$4,744
Agios Pharmaceuticals, Inc.
$4,357
Pharmacosmos Therapeutics Inc.
$3,616
Rigel Pharmaceuticals, Inc.
$3,418
ABBVIE INC.
$2,714
AstraZeneca Pharmaceuticals LP
$2,350
TAIHO ONCOLOGY, INC.
$2,162
Seagen Inc.
$2,148
Janssen Scientific Affairs, LLC
$1,791
Celgene Corporation
$1,737
Adaptive Biotechnologies Corporation
$1,708
Gilead Sciences, Inc.
$1,672
Astellas Pharma US Inc
$1,243
Sobi, Inc
$1,231
Novartis Pharmaceuticals Corporation
$1,153
Janssen Biotech, Inc.
$1,021
GENZYME CORPORATION
$559
BeiGene, Ltd.
$450
Genentech USA, Inc.
$383
Amgen Inc.
$366
Daiichi Sankyo Inc.
$319
NOVARTIS PHARMACEUTICALS CORPORATION
$299
Pharmacyclics LLC, An AbbVie Company
$205
Taiho Oncology, Inc.
$203
ARRAY BIOPHARMA INC
$194
Merck Sharp & Dohme LLC
$193
Lilly USA, LLC
$181
Boehringer Ingelheim Pharmaceuticals, Inc.
$163
Mirati Therapeutics, Inc.
$146
Bayer HealthCare Pharmaceuticals Inc.
$146
Karyopharm Therapeutics Inc.
$123
Octapharma USA, Inc.
$113
Merck Sharp & Dohme Corporation
$110
Kite Pharma, Inc.
$96
Global Blood Therapeutics, Inc.
$96
Foundation Medicine, Inc.
$86
Alexion Pharmaceuticals, Inc.
$86
TerSera Therapeutics LLC
$85
Array BioPharma Inc.
$69
Dendreon Pharmaceuticals LLC
$65
SUN PHARMACEUTICAL INDUSTRIES INC.
$60
Heron Therapeutics, Inc.
$60
EMD Serono, Inc.
$55
Alnylam Pharmaceuticals Inc.
$53
G1 Therapeutics, Inc.
$52
AMAG Pharmaceuticals, Inc.
$51
AbbVie Inc.
$48
MEDIVATION FIELD SOLUTIONS LLC
$47
CTI BioPharma Corp.
$46
Bayer Healthcare Pharmaceuticals Inc.
$46
RECORDATI_RARE_DISEASES_INC.
$41
ADC Therapeutics America, Inc.
$38
Inari Medical, Inc.
$38
Sumitomo Pharma America, Inc.
$37
Pharmacyclics LLC, an AbbVie Company
$32
PUMA BIOTECHNOLOGY, INC.
$32
Deciphera Pharmaceuticals Inc.
$31
Jazz Pharmaceuticals Inc.
$29
Blueprint Medicines Corporation
$29
Dova Pharmaceuticals
$25
Myovant Sciences Inc.
$25
Stemline Therapeutics Inc.
$24
Kyowa Kirin, Inc.
$24
Regeneron Healthcare Solutions, Inc.
$24
Acrotech Biopharma LLC
$24
Clovis Oncology, Inc.
$24
TG Therapeutics, Inc.
$23
SECURA BIO, INC.
$23
AVEO Pharmaceuticals, Inc.
$23
EISAI INC.
$22
Apellis Pharmaceuticals, Inc.
$21
Servier Pharmaceuticals LLC
$19
MACROGENICS, INC.
$19
Puma Biotechnology, Inc.
$18
Aurobindo Pharma USA, Inc.
$14
GT Medical Technologies, Inc
$13
EUSA Pharma (US) LLC
$13
Helsinn Therapeutics (U.S.), Inc.
$13
Epizyme, Inc.,
$12
Secura Bio, Inc.
$12
Lexicon Pharmaceuticals, Inc.
$11
Sirtex Medical Inc
$8
Top 3 companies account for 61.9% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AKYNZEO · ALUNBRIG · AYVAKIT · Alecensa · BAVENCIO · BELEODAQ · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CHANTIX · CINVANTI · COPIKTRA · COSELA · CYRAMZA · Cabometyx · Cinvanti · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · ERLEADA · Enhertu · Erivedge · Erleada · FARESTON · FARYDAK · FERAHEME · FLOWTRIEVER CATHETER · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Folotyn · GAZYVA · GILOTRIF · GIVLAARI · GammaTile · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INREBIC · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MARGENZA · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · NERLYNX · NINLARO · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Odomzo · Onivyde · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Padcev · Perjeta · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · RYDAPT · Rezlidhia · Rubraca · S · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SUTENT · SYLVANT · Somatuline Depot · Stivarga · Sylvant · TAGRISSO · TALVEY · TASIGNA · TAZVERIK · TIBSOVO · TIVDAK · TUKYSA · Tazverik · Tecentriq · Trodelvy · UKONIQ · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · Vanflyta · Vitrakvi · Vonjo · XALKORI · XOSPATA · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · YONSA · ZEPZELCA · ZIIHERA · Zoladex · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematologists in nearby ZIP areas
20
County median income
$77,011
Nearest hospital to ZIP centroid (approximate)
CENTRAL FLORIDA BEHAVIORAL HOSPITAL
5.0 mi
5.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shameem is a mixed practice specialist, with moderate Medicare volume, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shameem experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Shameem performed 10,200 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Shameem receive payments from pharmaceutical companies?
Yes. Dr. Shameem received a total of $668,012 from 93 companies across 1,204 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shameem's costs compare to other hematologists in Orlando?
Dr. Shameem's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shameem) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Orlando
Browse hematologists in Orlando ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in FL
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in FL
Which FL hematologists receive the most from drug and device companies.
By company
SOBI, INC Payments to Doctors
See all physicians who received payments from SOBI, INC.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
By company
Ipsen Biopharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Ipsen Biopharmaceuticals, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology